![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: AAR2 |
Gene summary for AAR2 |
![]() |
Gene information | Species | Human | Gene symbol | AAR2 | Gene ID | 25980 |
Gene name | AAR2 splicing factor | |
Gene Alias | C20orf4 | |
Cytomap | 20q11.23 | |
Gene Type | protein-coding | GO ID | GO:0000244 | UniProtAcc | Q9Y312 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
25980 | AAR2 | LZE4T | Human | Esophagus | ESCC | 3.16e-08 | 2.01e-01 | 0.0811 |
25980 | AAR2 | LZE7T | Human | Esophagus | ESCC | 1.33e-03 | 2.25e-01 | 0.0667 |
25980 | AAR2 | LZE8T | Human | Esophagus | ESCC | 4.41e-02 | 9.16e-02 | 0.067 |
25980 | AAR2 | LZE20T | Human | Esophagus | ESCC | 7.47e-03 | 1.99e-01 | 0.0662 |
25980 | AAR2 | LZE24T | Human | Esophagus | ESCC | 4.48e-25 | 5.83e-01 | 0.0596 |
25980 | AAR2 | P1T-E | Human | Esophagus | ESCC | 2.20e-04 | 2.18e-01 | 0.0875 |
25980 | AAR2 | P2T-E | Human | Esophagus | ESCC | 8.55e-19 | 3.85e-01 | 0.1177 |
25980 | AAR2 | P4T-E | Human | Esophagus | ESCC | 5.21e-15 | 3.85e-01 | 0.1323 |
25980 | AAR2 | P5T-E | Human | Esophagus | ESCC | 2.50e-08 | 1.71e-01 | 0.1327 |
25980 | AAR2 | P8T-E | Human | Esophagus | ESCC | 1.05e-22 | 4.03e-01 | 0.0889 |
25980 | AAR2 | P9T-E | Human | Esophagus | ESCC | 6.17e-10 | 2.18e-01 | 0.1131 |
25980 | AAR2 | P10T-E | Human | Esophagus | ESCC | 8.50e-21 | 4.54e-01 | 0.116 |
25980 | AAR2 | P11T-E | Human | Esophagus | ESCC | 5.38e-16 | 5.89e-01 | 0.1426 |
25980 | AAR2 | P12T-E | Human | Esophagus | ESCC | 7.48e-24 | 5.21e-01 | 0.1122 |
25980 | AAR2 | P15T-E | Human | Esophagus | ESCC | 1.11e-20 | 4.26e-01 | 0.1149 |
25980 | AAR2 | P16T-E | Human | Esophagus | ESCC | 2.97e-29 | 5.85e-01 | 0.1153 |
25980 | AAR2 | P17T-E | Human | Esophagus | ESCC | 6.17e-06 | 3.17e-01 | 0.1278 |
25980 | AAR2 | P19T-E | Human | Esophagus | ESCC | 6.53e-04 | 3.04e-01 | 0.1662 |
25980 | AAR2 | P20T-E | Human | Esophagus | ESCC | 3.77e-22 | 4.87e-01 | 0.1124 |
25980 | AAR2 | P21T-E | Human | Esophagus | ESCC | 4.53e-30 | 6.13e-01 | 0.1617 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0022613111 | Esophagus | ESCC | ribonucleoprotein complex biogenesis | 365/8552 | 463/18723 | 1.74e-49 | 1.11e-45 | 365 |
GO:0008380111 | Esophagus | ESCC | RNA splicing | 336/8552 | 434/18723 | 1.74e-42 | 3.67e-39 | 336 |
GO:0000375111 | Esophagus | ESCC | RNA splicing, via transesterification reactions | 248/8552 | 324/18723 | 3.05e-30 | 1.49e-27 | 248 |
GO:0000377111 | Esophagus | ESCC | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 244/8552 | 320/18723 | 2.52e-29 | 1.07e-26 | 244 |
GO:0000398111 | Esophagus | ESCC | mRNA splicing, via spliceosome | 244/8552 | 320/18723 | 2.52e-29 | 1.07e-26 | 244 |
GO:0071826111 | Esophagus | ESCC | ribonucleoprotein complex subunit organization | 166/8552 | 227/18723 | 2.94e-17 | 2.42e-15 | 166 |
GO:0022618111 | Esophagus | ESCC | ribonucleoprotein complex assembly | 159/8552 | 220/18723 | 8.19e-16 | 5.71e-14 | 159 |
GO:00003875 | Esophagus | ESCC | spliceosomal snRNP assembly | 32/8552 | 50/18723 | 6.90e-03 | 2.52e-02 | 32 |
GO:002261322 | Liver | HCC | ribonucleoprotein complex biogenesis | 355/7958 | 463/18723 | 7.76e-52 | 4.92e-48 | 355 |
GO:000838022 | Liver | HCC | RNA splicing | 313/7958 | 434/18723 | 1.36e-36 | 1.73e-33 | 313 |
GO:000037522 | Liver | HCC | RNA splicing, via transesterification reactions | 228/7958 | 324/18723 | 1.47e-24 | 4.06e-22 | 228 |
GO:000037722 | Liver | HCC | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 224/7958 | 320/18723 | 1.16e-23 | 2.62e-21 | 224 |
GO:000039822 | Liver | HCC | mRNA splicing, via spliceosome | 224/7958 | 320/18723 | 1.16e-23 | 2.62e-21 | 224 |
GO:007182622 | Liver | HCC | ribonucleoprotein complex subunit organization | 159/7958 | 227/18723 | 3.14e-17 | 3.06e-15 | 159 |
GO:002261822 | Liver | HCC | ribonucleoprotein complex assembly | 153/7958 | 220/18723 | 3.44e-16 | 2.91e-14 | 153 |
GO:00003872 | Liver | HCC | spliceosomal snRNP assembly | 31/7958 | 50/18723 | 4.23e-03 | 1.84e-02 | 31 |
GO:002261320 | Oral cavity | OSCC | ribonucleoprotein complex biogenesis | 333/7305 | 463/18723 | 8.28e-48 | 5.24e-44 | 333 |
GO:000838020 | Oral cavity | OSCC | RNA splicing | 308/7305 | 434/18723 | 2.43e-42 | 7.70e-39 | 308 |
GO:000037519 | Oral cavity | OSCC | RNA splicing, via transesterification reactions | 225/7305 | 324/18723 | 5.20e-29 | 2.99e-26 | 225 |
GO:000037719 | Oral cavity | OSCC | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 221/7305 | 320/18723 | 5.50e-28 | 2.18e-25 | 221 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
AAR2 | SNV | Missense_Mutation | c.304N>A | p.Pro102Thr | p.P102T | Q9Y312 | protein_coding | tolerated(0.37) | possibly_damaging(0.524) | TCGA-CD-A4MJ-01 | Stomach | stomach adenocarcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | CR | |
AAR2 | SNV | Missense_Mutation | rs375933541 | c.1057N>A | p.Ala353Thr | p.A353T | Q9Y312 | protein_coding | tolerated(0.29) | benign(0.125) | TCGA-HU-A4GU-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
AAR2 | SNV | Missense_Mutation | novel | c.251G>T | p.Arg84Leu | p.R84L | Q9Y312 | protein_coding | deleterious(0.02) | probably_damaging(0.946) | TCGA-DJ-A2PX-01 | Thyroid | thyroid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |